Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and
Molecular Imaging (SNMMI) are presenting a molecular imaging technique that allows oncologists to set patients» radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vita
Molecular Imaging (SNMMI) are presenting a molecular imaging technique that allows oncologists to set patients» radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital
Imaging (SNMMI) are presenting a
molecular imaging technique that allows oncologists to set patients» radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vita
molecular imaging technique that allows oncologists to set patients» radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital
imaging technique that allows oncologists to set patients» radiotherapy doses right at that critical limit of
delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital organs.